In this issue
mAbs
Volume 1, Issue 4July/August 2009
View current issue
About the cover
Human diseases are complex and often involve multiple mediators contributing to disease pathogenesis. Therefore, a therapeutic agent that inhibits multiple...Continue reading
Issue Highlights
About the Journal
In January of 2009 mAbs, the first international peer-reviewed journal of its kind to focus exclusively on monoclonal antibodies, was launched. We believe that this is an excellent time to start the journal because of the increasing focus on mAbs as therapeutics. There has been a rapid increase in mAb R&D by academia, government and industry located world wide. Novel mAb therapeutics are entering clinical study by commercial sponsors at a record pace (Figure 1) that is predicted to continue well into the future. MAbs have proven successful in the clinic (Table 1). In addition, a global market has emerged for the products - several novel mAbs not yet available in the US or EU are now approved in China.
Editor-in-Chief
Janice M. Reichert, Ph.D.
Email the Managing Editor.
Print ISSN: 1942-0862
Online ISSN: 1942-0870 DOI: 10.4161/mabs
Online ISSN: 1942-0870 DOI: 10.4161/mabs
Most Popular Downloads
01 Jul 09
Human immunoglobulin allotypes: Possible implications for immunogenicity
Roy Jefferis, Marie-Paule Lefranc
Roy Jefferis, Marie-Paule Lefranc
01 Jul 09
Upcoming meetings
Janice M. Reichert
Janice M. Reichert
01 Jul 09
Inhibitory effects of persistent apoptotic cells on monoclonal antibody production in vitro: Simple removal of non-viable cells improves antibody productivity by hybridoma cells in culture
Christopher D. Gregory, John D. Pound, Andrew Devitt, et al.
Christopher D. Gregory, John D. Pound, Andrew Devitt, et al.
Meetings of interest
9th Congress of the European Association for Clinical Pharmacology and Therapeutics
July 12–15, 2009 Edinburgh Scotland
Monoclonal Antibodies
July 14, 2009 Washington, DC USA
3rd Latin American Congress on Autoimmunity
July 30–August 01, 2009 Buenos Aires Argentina
July 12–15, 2009 Edinburgh Scotland
Monoclonal Antibodies
July 14, 2009 Washington, DC USA
3rd Latin American Congress on Autoimmunity
July 30–August 01, 2009 Buenos Aires Argentina
Attention Authors
Page charges for manuscripts accepted into Volume 1, Issue 5 and Volume 1, Issue 6 are waived. Please note that all other fees, including color and reprint costs apply. Please see the For Authors section for additional information or contact the Managing Editor for questions.
Advertisements
